Blue Sail Medical Stock Revenue
| 002382 Stock | 5.58 0.02 0.36% |
Blue Sail Medical fundamentals help investors to digest information that contributes to Blue Sail's financial success or failures. It also enables traders to predict the movement of Blue Stock. The fundamental analysis module provides a way to measure Blue Sail's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Blue Sail stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 4.9 B | 2.8 B |
Blue | Revenue |
Blue Sail Medical Company Revenue Analysis
Blue Sail's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Blue Sail Revenue | 4.93 B |
Most of Blue Sail's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Blue Sail Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Blue
Projected quarterly revenue analysis of Blue Sail Medical provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Blue Sail match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Blue Sail's stock price.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Blue Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Blue Sail Medical reported 4.93 B of revenue. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The revenue for all China stocks is notably lower than that of the firm.
Blue Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Blue Sail's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Blue Sail could also be used in its relative valuation, which is a method of valuing Blue Sail by comparing valuation metrics of similar companies.Blue Sail is currently under evaluation in revenue category among its peers.
Blue Fundamentals
| Return On Equity | -0.0442 | ||||
| Return On Asset | -0.0129 | ||||
| Profit Margin | (0.07) % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 7.05 B | ||||
| Shares Outstanding | 1.01 B | ||||
| Shares Owned By Insiders | 33.38 % | ||||
| Shares Owned By Institutions | 1.14 % | ||||
| Price To Book | 0.63 X | ||||
| Price To Sales | 0.93 X | ||||
| Revenue | 4.93 B | ||||
| Gross Profit | 419.17 M | ||||
| EBITDA | 198.28 M | ||||
| Net Income | (568.36 M) | ||||
| Total Debt | 3.86 B | ||||
| Book Value Per Share | 8.82 X | ||||
| Cash Flow From Operations | (72.89 M) | ||||
| Earnings Per Share | (0.44) X | ||||
| Target Price | 24.02 | ||||
| Number Of Employees | 8.09 K | ||||
| Beta | 0.48 | ||||
| Market Capitalization | 5.59 B | ||||
| Total Asset | 15.63 B | ||||
| Retained Earnings | 2.12 B | ||||
| Working Capital | (139.09 M) | ||||
| Net Asset | 15.63 B |
About Blue Sail Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Blue Sail Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Blue Sail using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Blue Sail Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Blue Stock
Blue Sail financial ratios help investors to determine whether Blue Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Blue with respect to the benefits of owning Blue Sail security.